Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

brincidofovir

brincidofovir
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Tembexa SUSPENSION, ORAL 10 mg/mL      
Tembexa TABLET, ORAL 100 mg      
Comments:

Restricted to use by infectious diseases prescribers following CDC guidelines. Use currently limited to treatment of smallpox and monkeypox. Must be obtained through the CDC application process & distributed from the Strategic National Stockpile.

Reviewed: August 2022 (Tembexa)

 

BBW

Last updated: Jan. 18, 2023






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved